540 related articles for article (PubMed ID: 11045151)
1. [Leukemic transformation of polycythemia vera after treatment with hydroxyurea and chromosome 17 abnormalities].
Tóthová E; Nebesnáková E; Kafková A; Stecová N; Fricová M
Vnitr Lek; 1999 Aug; 45(8):487-9. PubMed ID: 11045151
[TBL] [Abstract][Full Text] [Related]
2. Leukemic transformation of polycythemia vera after treatment with hydroxyurea with abnormalities of chromosome 17.
Tóthová E; Fricová M; Stecová N; Hlebasková M; Kafková A; Raffac S; Guman T; Svorcová E; Nebesnáková E
Neoplasma; 2001; 48(5):389-92. PubMed ID: 11845984
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment with interferon-alpha in a case of acute myeloid leukemia with del (20q) following polycythemia vera].
Sumi M; Tauchi T; Takaku T; Ohyashiki JH; Ohyashiki K
Rinsho Ketsueki; 2005 Nov; 46(11):1208-12. PubMed ID: 16440805
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea.
Cacciola E; Cacciola RR; Guglielmo P; Stagno F; Giustolisi R
Haematologica; 1999 Aug; 84(8):755-6. PubMed ID: 10457418
[No Abstract] [Full Text] [Related]
5. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
Swolin B; Rödjer S; Westin J
Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
[TBL] [Abstract][Full Text] [Related]
6. Long-term management of polycythemia vera with hydroxyurea: a progress report.
Kaplan ME; Mack K; Goldberg JD; Donovan PB; Berk PD; Wasserman LR
Semin Hematol; 1986 Jul; 23(3):167-71. PubMed ID: 3749925
[No Abstract] [Full Text] [Related]
7. Tumor lysis syndrome induced by hydroxyurea therapy for leukemic transformation of polycythemia vera.
Ellis AK; Lee DH
Am J Hematol; 2002 Nov; 71(3):237-8. PubMed ID: 12410589
[No Abstract] [Full Text] [Related]
8. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
[TBL] [Abstract][Full Text] [Related]
9. Dermatomyositis-like eruption after long-term hydroxyurea therapy for polycythemia vera.
Oskay T; Kutluay L; Ozyilkan O
Eur J Dermatol; 2002; 12(6):586-8. PubMed ID: 12459535
[TBL] [Abstract][Full Text] [Related]
10. Treatment of polycythemia vera with hydroxyurea and pipobroman: final results of a randomized trial initiated in 1980.
Kiladjian JJ; Chevret S; Dosquet C; Chomienne C; Rain JD
J Clin Oncol; 2011 Oct; 29(29):3907-13. PubMed ID: 21911721
[TBL] [Abstract][Full Text] [Related]
11. Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.
Alvarez-Larrán A; Martínez-Avilés L; Hernández-Boluda JC; Ferrer-Marín F; Antelo ML; Burgaleta C; Mata MI; Xicoy B; Martínez-Trillos A; Gómez-Casares MT; Durán MA; Marcote B; Ancochea A; Senín A; Angona A; Gómez M; Vicente V; Cervantes F; Bellosillo B; Besses C
Ann Hematol; 2014 Dec; 93(12):2037-43. PubMed ID: 24981691
[TBL] [Abstract][Full Text] [Related]
12. Oral squamous cell carcinoma during long-term treatment with hydroxyurea.
De Benedittis M; Petruzzi M; Giardina C; Lo Muzio L; Favia G; Serpico R
Clin Exp Dermatol; 2004 Nov; 29(6):605-7. PubMed ID: 15550132
[TBL] [Abstract][Full Text] [Related]
13. Leukemic transformation in three patients with polycythemia vera. Analysis of the clinicopathological features and N-ras gene mutation.
Sakai H; Karasawa M; Okamoto K; Maehara T; Tsukamoto N; Murakami H; Naruse T; Morita K; Tsuchiya J
J Med; 1996; 27(3-4):183-91. PubMed ID: 8982966
[TBL] [Abstract][Full Text] [Related]
14. Indications, procedure and results for the treatment of polycythaemia vera by bleeding, pipobroman and hydroxyurea.
Boivin P
Nouv Rev Fr Hematol (1978); 1993; 35(5):491-8. PubMed ID: 8295823
[TBL] [Abstract][Full Text] [Related]
15. Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene.
Tiziana Storlazzi C; Pieri L; Paoli C; Daniele G; Lasho T; Tefferi A; Vannucchi AM
Am J Hematol; 2014 Apr; 89(4):438-42. PubMed ID: 24382738
[TBL] [Abstract][Full Text] [Related]
16. Translocation t(3;21)(q26;q22) in acute myeloblastic leukemia secondary to polycythemia vera.
Dastugue N; Pris J; Colombies P
Cancer Genet Cytogenet; 1990 Feb; 44(2):275-6. PubMed ID: 2297687
[TBL] [Abstract][Full Text] [Related]
17. Eosinophilic leukemic transformation in polycythemia rubra vera (PRV).
Chim CS; Ma SK
Leuk Lymphoma; 2005 Mar; 46(3):447-50. PubMed ID: 15621837
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia evolving from polycythemia vera in a patient treated with hydroxyurea.
Pulik M; Lionnet F; Genet P; Petitdidier C; Jary L; Touahri T
Am J Hematol; 1996 Nov; 53(3):207-8. PubMed ID: 8895700
[No Abstract] [Full Text] [Related]
19. Hypereosinophilic syndrome associated with polycythemia vera.
Varon D; Wetzler M; Berrebi A
Arch Intern Med; 1986 Jul; 146(7):1440-1. PubMed ID: 3718142
[TBL] [Abstract][Full Text] [Related]
20. From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera.
Fruchtman SM; Mack K; Kaplan ME; Peterson P; Berk PD; Wasserman LR
Semin Hematol; 1997 Jan; 34(1):17-23. PubMed ID: 9025158
[No Abstract] [Full Text] [Related]
[Next] [New Search]
